Get Real Time Here
| Open1.710 | Close- |
| Vol / Avg.536.603K / 903.003K | Mkt Cap132.182M |
| Day Range1.700 - 1.890 | 52 Wk Range0.545 - 2.530 |
BioLine Rx Stock (NASDAQ:BLRX), Quotes and News Summary
BioLine Rx Stock (NASDAQ: BLRX) stock price, news, charts, stock research, profile.
| Open1.710 | Close- |
| Vol / Avg.536.603K / 903.003K | Mkt Cap132.182M |
| Day Range1.700 - 1.890 | 52 Wk Range0.545 - 2.530 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.210 | -0.260 | -0.0500 | ||||
| REV | 0 |
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.300 | ||||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-11-20 | HC Wainwright & Co. | Joseph Pantginis | Reiterates | BuyBuy | Maintains | - | 21.00 |
| 2023-09-15 | HC Wainwright & Co. | Joseph Pantginis | Maintains | BuyBuy | Raises | 19.00 | 21.00 |
| 2023-08-31 | HC Wainwright & Co. | Joseph Pantginis | Reiterates | BuyBuy | Maintains | - | 19.00 |
| 2023-05-25 | Oppenheimer | Mark Breidenbach | Reiterates | Outperform | Maintains | - | 4.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| BLRX | BioLine Rx | 7.02% | 132.2M |
| OTLK | Outlook Therapeutics | -2.86% | 111.8M |
| GRPH | Graphite Bio | -4.85% | 125.3M |
| GALT | Galectin Therapeutics | 4.66% | 124.9M |
| BRNS | Barinthus Biotherapeutics | -0.16% | 119.2M |
How do I buy BioLine Rx (BLRX) stock?
You can purchase shares of BioLine Rx (NASDAQ: BLRX) through any online brokerage.
Who are BioLine Rx's (BLRX) competitors?
Other companies in BioLine Rx’s space includes: Outlook Therapeutics (NASDAQ:OTLK), Graphite Bio (NASDAQ:GRPH), Galectin Therapeutics (NASDAQ:GALT), Barinthus Biotherapeutics (NASDAQ:BRNS) and Adaptimmune Therapeutics (NASDAQ:ADAP).
What is the target price for BioLine Rx (BLRX) stock?
The latest price target for BioLine Rx (NASDAQ: BLRX) was reported by HC Wainwright & Co. on Monday, November 20, 2023. The analyst firm set a price target for 21.00 expecting BLRX to rise to within 12 months (a possible 1047.54% upside). 4 analyst firms have reported ratings in the last year.
Current Stock Price for BioLine Rx (BLRX)?
The stock price for BioLine Rx (NASDAQ: BLRX) is $1.83 last updated Today at December 8, 2023 at 7:08 PM UTC.
Does BioLine Rx (BLRX) pay a dividend?
There is no dividend information for BioLine Rx.
When is BioLine Rx (NASDAQ:BLRX) reporting earnings?
BioLine Rx’s Q3 earnings are confirmed for Monday, November 20, 2023.
Is BioLine Rx (BLRX) going to split?
There is no upcoming split for BioLine Rx.
What sector and industry does BioLine Rx (BLRX) operate in?
BioLine Rx is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.